Cart
sales@molnova.com
Phenamacril
CAS No. 39491-78-6
Phenamacril( JS399 19 | JS39919 | JS399-19 )
Catalog No. M27773 CAS No. 39491-78-6
JS399-19 is acyanoacrylate fungicide, has powerful inhibition against Fusarium species, especially to Fusarium graminearum. JS399-19 is a specific Fusarium myosin I inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 302 | Get Quote |
|
| 10MG | 447 | Get Quote |
|
| 25MG | 714 | Get Quote |
|
| 50MG | 1017 | Get Quote |
|
| 100MG | 1368 | Get Quote |
|
| 500MG | 2673 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePhenamacril
-
NoteResearch use only, not for human use.
-
Brief DescriptionJS399-19 is acyanoacrylate fungicide, has powerful inhibition against Fusarium species, especially to Fusarium graminearum. JS399-19 is a specific Fusarium myosin I inhibitor.
-
DescriptionJS399-19 is acyanoacrylate fungicide, has powerful inhibition against Fusarium species, especially to Fusarium graminearum. JS399-19 is a specific Fusarium myosin I inhibitor.
-
In Vitro——
-
In Vivo——
-
SynonymsJS399 19 | JS39919 | JS399-19
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetMyosin
-
RecptorMRP4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number39491-78-6
-
Formula Weight216.24
-
Molecular FormulaC12H12N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCOC(=O)C(\C#N)=C(/N)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ya Chen, et al. Discovery of novel multidrug resistance protein 4 (MRP4) inhibitors as active agents reducing resistance to anticancer drug 6-Mercaptopurine (6-MP) by structure and ligand-based virtual screening. PLoS One. 2018 Oct 15;13(10):e0205175.
molnova catalog
related products
-
para-Nitroblebbistat...
para-Nitroblebbistatin is a non-cytotoxic, non-fluorescent, photostable, and specific inhibitor of myosin II.
-
BTS
A highly specific myosin II ATPase inhibitor; inhibits the Ca2+-stimulated S1 ATPase, and reversibly blocked gliding motility.
-
MS-444
MS-444 (BE-34776) is a smooth muscle myosin light chain kinase (MLCK) and HuR inhibitor with antitumor activity for triple-negative breast and colorectal cancer.
